497
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of four cleaning solutions for the decontamination of selected cytotoxic drugs on the different surfaces of an automated compounding system

, , , &

References

  • Böhlandt, A., and Schierl, R.: Benefits of wipe sampling: Evaluation of long-term 5-fluorouracil and platinum monitoring data. Pharm. Technol. Hosp. Pharm. 1(3):139–150 (2016).
  • Fleury-Souverain, S., M. Mattiuzzo, F. Mehl, et al.: Evaluation of chemical contamination of surfaces during the preparation of chemotherapies in 24 hospital pharmacies. Eur. J. Hosp. Pharm. 22:333–341 (2015).
  • Berruyer, M., C. Tanguay, N.J. Caron, M. Lefebvre, and F. Bussieres: Multicenter study of environmental contamination with antineoplastic drugs in 36 Canadian hospitals: A 2013 follow-up study. J. Occup. Environ. Hyg. 12:87–94 (2015).
  • Connor, T.H., C.C. Lawson, M. Polovich, and M.A. McDiarmid: Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: A review of the evidence. J. Occup. Environ. Med. 56(9):901–910 (2014).
  • Fransman, W., R. Vermeulen, and H. Kromhout: Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int. Arch. Occup. Environ. Health 78:403–12 (2005).
  • National Institute for Occupational Safety and health (NIOSH): “Preventing occupational exposure to antineoplastic and other hazardous drugs in healthcare settings.” Cincinnati, Ohio: NIOSH 2004. Available at http://cdc.gov/niosh/docs/2004-165/.
  • International Society of Oncology Pharmacy Practitioners: ISOPP Standards of practice. Safe handling of cytotoxics. J. Oncol. Pharm. Pract. 13(Suppl):1–81 (2007).
  • US Pharmacopeial Convention: Chapter <800> Hazardous drugs – Handling in healthcare settings. In The United States Pharmacopeia, 40th rev, and The National Formulary, 35th ed. First supplement. Rockville, MD: US Pharmacopeial Convention; 2017.
  • Schierl, R., C. Masini, S. Groeneveld, et al.: Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo. J. Oncol. Pharm. Pract. 22:37–45 (2014).
  • Iwamoto, T., T. Morikawa, M. Hioki, H. Sudo, D. Paolucci, and M. Okuda: Performance evaluation of the compounding robot APOTECAchemo for injectable anticancer drugs in a Japanese hospital. J. Pharm. Health Care Sci. 3:12 (2017).
  • Krämer, I., M. Federici, and R. Schierl: Environmental and product contamination during the preparation of antineoplastic drugs with robotic systems. Pharm. Technol. Hosp. Pharm. (2018). [In Press] Epub ahead of print, https://doi.org/10.1515/pthp-2018-0018
  • Roberts, S., N. Khammo, G. McDonnell, and G. Sewell: Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations. J. Oncol. Pharm. Pract. 12:95–104 (2006).
  • Lamerie, T., S. Nussbaumer, B. Décaudin, et al.: Evaluation of decontamination efficacy of cleaning solutions on stainless steel and glass surfaces contaminated by 10 antineoplastic agents. Ann. Occup. Hyg. 57(4):456–469 (2013).
  • Touzin, K., J. Bussières, E. Langlois, M. Lefebvre, and A. Metra: Pilot study comparing the efficacy of two cleaning techniques in reducing environmental contamination with cyclophosphamide. Ann. Occup. Hyg. 54(3):351–359 (2010).
  • Lê, L., P. Jolivot, H. Yaye, et al.: Effectiveness of cleaning of workplace cytotoxic surface. Int. Arch. Occup. Environ. Health 86:333–341 (2003).
  • Hon, C.Y., P. Chua, Q. Danyluk, and G. Astrakianakis: Examining factors that influence the effectiveness of cleaning antineoplastic drugs from drug preparation surfaces: A pilot study. J. Oncol. Pharm. Pract. 20(3):210–216 (2014).
  • Cox, J., V. Speed, S. O’Neal, et al.: Development and evaluation of a novel product to remove surface contamination of hazardous drugs. J. Oncol. Pharm. Pract. 23(2):103–115 (2015).
  • Böhlandt, A., S. Groeneveld, E. Fischer, and R. Schierl: Cleaning efficacies of three cleaning agents on four different surfaces after contamination by gemcitabine and 5-fluorouracil. J. Occup. Environ. Hyg. 12:384–392 (2015).
  • Roland, C., A. Adè, J. Oullette-Frève, S. Gagnè, N. Caron, and J. Bussieres: Pilot study evaluating the efficacy of four cleaning solutions and two types of mops in delimited areas of a floor contaminated with cyclophosphamide. Pharm. Technol. Hosp. Pharm. 2(3):99–106 (2017).
  • Gohma, H., Y. Onoue, M. Asano, and S. Sugiura: Testing the degradation effects of three reagents on various antineoplastic compounds. J. Oncol. Pharm. Pract. 21(4):268–273 (2015).
  • Benvenuto, J., T.H. Connor, D. Monteith, et al.: Degradation and inactivation of antitumor drugs. J. Pharm. Sci. 82:988–991 (1993).
  • Hansel, S., M. Castegnaro, M.H. Sportouh, et al.: Chemical degradation of wastes of antineoplastic agents: Cyclophosphamide, ifosfamide and melphalan. Int. Arch. Occup. Environ. Health 69:109–114 (1997).
  • Castegnaro, M., M. De Meo, M. Laget, et al.: Chemical degradation of wastes of antineoplastic agents. Int. Arch. Occup. Environ. Health 70(6):378–384 (1997).
  • Barek, J., J. Cvacka, M. De Meo, et al.: Chemical degradation of wastes of antineoplastic agents amsacrine, azathioprine, asparaginase and thiotepa. Ann. Occup. Hyg. 42(4):259–266 (1998).
  • Schmaus, G., R. Schierl, and S. Funck: Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am. J. Health-Syst. Pharm. 59:956–961 (2002).
  • Schierl, R., A. Böhlandt, and D. Nowak: Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Ann. Occup. Hyg. 53(7):703–711 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.